ZYMAXID
Active substance: gatifloxacin
SOLUTION/ DROPS · GATIFLOXACIN 5 mg/mL
United StatesActive
Marketing holder: Allergan, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- GATIFLOXACIN · 5 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-cbdf-74ba-b13f-31a4a825a240,01a12092-4ed9-7f3c-9a4e-d2a274a33351,01a12092-6c18-7c52-9bb6-d7c616c9f63a,01a12096-873f-7a5f-841b-789a8dbd5c49;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0023-3615
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- OPHTHALMIC
Sources
- product · openFDA NDC · 0023-3615 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0023-3615 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0023-3615 · Verified 2026-10-09 · open in source